Sep 16, 2020 / 12:00PM GMT
David Ryan Lewis - Morgan Stanley, Research Division - MD
Well, good morning, everyone, and welcome to day 3 of the Morgan Stanley healthcare conference 2020. My name is David Lewis, medical device analyst at Morgan Stanley, and thanks for your -- for joining us bright and early, earlier for me than for you on the East Coast.
It's my pleasure to kind of kick off day 3 here with one of our large-cap companies, Boston Scientific. We have both their CEO, Michael Mahoney; as well as their CFO, Dan Brennan. Pleased to have you both this morning.
And with that, we're ready for action.
Questions and Answers:
David Ryan Lewis - Morgan Stanley, Research Division - MDSo team, I thought we'd start off where I'd been starting off kind of all week and just talk about COVID-19 recovery, your thoughts and anything you're willing to share here post the quarter. How have month-on-month trends been here in the third quarter? Most of our companies have talked about kind of nice sequential month-on-month improvement. I just wondered if you could comment